Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia by unknown
PREFERENTIAL LINKAGE OF BCL-2 TO
IMMUNOGLOBULIN LIGHT CHAIN GENE IN CHRONIC
LYMPHOCYTIC LEUKEMIA
BY MASAAKI ADACHI,* AYALEW TEFFERI,: PHILIP R. GREIPP,x
THOMAS J. KIPPS,§ AND YOSHIHIDE TSUJIMOTO*
From *The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104; the IMayo
Clinic, Division of Hematology, Department of Internal Medicine, Rochester, Minnesota 55905; and
the §Research Institute of Scripps Clinic, La Jolla, California 92037
Nonrandom chromosome aberrations are associated with human malignancies
and believed to play a key role in the pathogenesis of these diseases by disturbing
cellular genes involved in the control ofcell growth. The human bcl-2 gene was the
first tobe identified bythe study ofchromosome abnormalities associated with human
neoplasms(1-3). About 90% offollicular B celllymphoma and -20% oflargediffuse
B celllymphoma carry thet(14;18)(g32;q21) translocation (4), whichdirectly involves
theIgHlocus on chromosome 14and thebcl-2 gene on chromosome 18. Thet(14;18)
translocation occurs nearly exclusively at two loci, a major breakpoint clustering
region within the 3' noncoding region and the minor breakpoint clustering region
within the 3' flanking region of the bcl-2 gene (1, 5).
It has recently been reported that the bcl-2 gene product plays a dominant role
in cell survival (6-8), which could be a key step for neoplastic transformation of
Blymphocytes. This biological function ofthebcl-2 gene product ledustospeculate
that the spectrum ofbcl-2 gene involvement in B cell malignancies might be broad.
In fact, we have recently reported a case of chronic lymphocytic leukemia (CLL)
with the bcl-2/IgXjuxtaposition (9). In this article we have extended this study and
shown that a significant fraction ofCLL carries the bcl-2 rearrangements and that
in all cases studied, rearrangements ofthe bcl-2 gene were the results ofjuxtaposi-
tion of the 5' region of bcl-2 gene and one of the IgL genes.
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Materials and Methods
BriefDefinitive Report
CLL Samples.
￿
CLL2 (IgMA) and CLL26 (IgMK) co-expressed CD5, CD19, and CD20
as assessed by flowcytometry. The circulatinglymphocytes in both cases appeared morpho-
logically mature and phenotypically characteristic ofB cell CLL. Our trial ofkaryotyping
of CLL2 and CLL26 was unsuccessful.
DNA Probes.
￿
ThepB16 probe contains a part ofthefirst exon ofthe bcl-2 gene (10). The
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pB3 probe spans the major breakpoint clustering region of t(14;18) translocation, which is
localized within the second exon of the bcl-2 gene (10). The pFL-2 probe lies more than 20
kb downstream from the second exon of the bcl-2 gene and detects most t(14;18) transloca-
tions, the breakpoints ofwhich do not fall in the major breakpoint clustering region (5) . DNA
probes were s2p labeled by nick translation .
Southern Blot Analysis.
￿
High molecular weight DNA, isolated from peripheral leukemia
cells and from healthyhuman placenta as acontrol, was digested with restriction endonucleases,
run on 0.7% agarose, and blotted to a nitrocellulose filter as described (9) .
Construction ofthe GenomicDNA Libraries.
￿
DNAs were partially digested with Sau3AI en-
zyme, andDNA fragments between 15 and 23 kb were ligated withXEMBL3A phage vector
and packaged in vitro as described (9) .
DNA Sequencing .
￿
Nucleotide sequences were determined by the dideoxy chain termina-
tion method as described (11) .
Results and Discussion
32 fresh specimens of CLL cases were collected from the National Institutes of
Health (two cases) (9), Scripps Clinic (20 cases), and the Mayo Clinic (10 cases),
and screened for bcl-2 gene rearrangement using Southern blot analysis . The bcl-2
gene probes used include pBl6 (10) (a part ofthe bcl-2 first exon), pB3 (10) (the major
breakpoint clustering region ofthe t(14;18) translocation), and pFL-2 (5) (the minor
breakpoint clustering region) . Of the 32 CLL samples, three cases (CLL1446 [9],
CLL2, and CLL26) showed the rearrangements ofthe bcl-2 gene that were detected
with the pB16 probe. No case showed any rearrangement with the pB3 and pFL-2
probe . Fig. 1 shows a Southern blot analysis of CLL2 (Fig . 1 A) and CLL26 (Fig.
FIGURE 1.
￿
Rearrangement of
the bcl-2 gene in CLLs . The
Southern blots of CLL2 (A,
lanes 1 and 3),CLL26 (B, lanes
1 and 3), and human placenta
DNA (A and B, lanes 2 and 4)
digested with Hind III (A and
B, lanes I and 2) and Barn HI
(A andB, lanes 3 and 4) were hy-
bridized with 32P-labeled pB16
probe. CLL2 and CLL26DNA
digested with Hind III and Barn
HI revealed additionalhybridiz-
ing fragments that represent the
rearranged bcl-2 gene . The size
is given in kilobases .1 B) DNAs with the pB16 probe, in which both revealed distinct rearranged frag-
ments with Bam HI and Hind III restriction enzymes. Thus, a significant fraction
(-10%) of CLL involves the rearrangement of the bcl-2 first exon region.
Genomic libraries were prepared from CLL2 and CLL26 DNAsusing AEMBL3A
vector and screened with pB16 probe as described (9). The XC2 and XC26 were rep-
resentativeclones containing therearranged bcl-2 geneofCLL2 and CLL26, respec-
tively (Fig. 2). Acomparison ofthe restriction maps ofthese clones with maps of
normal bcl-2, IgX, and Iga genes proved physical linkage between the bcl-2 gene
and IgXlocusin XC2 clone, and Igu locus in XC26clone, in a head-to-head configu-
ration. We determined the nucleotide sequences in the vicinity of the breakpoints
and the relevant portions of the bcl-2 and IgLs loci (Fig. 3). The breakpoints on
chromosome 18 were mappedwithin the 5' flanking region ofthebcl-2 gene (-1,100
and 600 by upstream from the 5' end ofcDNA [10] in CLL2 and CLL26, respec-
tively). In addition to these two CLL samples, a third (CLL1446) has been shown
to carry the bcl-2/Iga rearrangement, the breakpoint ofwhich was mapped -50 by
upstream from the 5' end ofcDNA (10), suggesting a hot spot for rearrangements
in CLL at the 5' flanking region of bcl-2 gene. The breakpoints on IgL loci were
mapped within the VX (subclass III) of the VXJXjoining product in CLL2 (Fig.
3 A) and within the 5' flanking region ofJK4 in CLL26 (Fig. 3 B). Analysis of the
reciprocal recombinant ofthe XC26 clone has shown that a Vic gene rearranged to
JK3 (Fig. 2). It is interesting that the breakpoints of the bcl-2/IgL juxtapositions
in CLL2 and CLL26 arelocated near(-20 and 150 bp, respectively) theVJjoining
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FIGURE 2.
￿
Juxtaposition ofbcl-2 and IgLgenesin CLLs. Thetopline represents thestructure
of thebcl-2 gene. The first exon of the bcl-2 gene is shown by the filled box. The transcription
direction of the bcl-2 gene is from left to right. The structures of IgL loci, Ca (15), CM (16),
andCX2(16) in agermline areshown at the bottom. J segments and constant regions are indi-
cated by open boxes. The bcl-2 and IgLs loci are shown by thick and thin lines, respectively.
Structures of the rearranged bcl-2 gene in CLL, 26, and 1446 are shown in the middle. The
XC26 andXC26HB (reciprocal recombinant) were derived from CLL26, andXC2wasfrom CLL2.
The X1446-3 (9) and X1446-20 (reciprocal recombinant) (11) were derived from CLL1446 and
are shownforcomparison.Thestippled box in XC2 andthecross-hatched box in XC26HB indi-
cate VXJX2 andVKJa3joining product, respectively. Thevertical arrows indicatethebreakpoints.
Therestriction sites are shown by: Barn HI ("), Eco RI ([I), andSst I (A). All Sst I sites are
not shown in CX1.562
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FIGURE 3 .
￿
Nucleotide sequences ofthe regions involved in the bcl-2/IgLjuxtaposition inCLL .
Thesequences derived from the germline chromosome 18 are shadowed . The triangles indicate
the breakpoints . (A) In CLL2, the breakpoint of IgX locus is located within the FR3 ofVX sub-
group III (17), which was aberrantly rearranged with JX2 (FR4), since the VXJXjoining is out
of the frame. The nucleotide sequences of the lower strand of the XC2 clone are presented in
3' to 5' direction to showthe readingframe oftheVXJXjoiningproduct . (B) In CLL26, the break-
point on Iglc locus is located within the flanking region between JIC3 (15) and JK4 (15) .
sites . This might reflect that the VJ joining product could remain activated, and
undergo further rearrangements with newV genes, thus producing additional vari-
ations in the VJ product .
As described above, no case of CLL showed any rearrangement with the bcl-2
probes that detect the major and minorbreakpoint clustering regions of the t(14;18)
translocation . Conversely, in follicular lymphoma the bcl-2 gene is commonly rear-
ranged within these two breakpoint clustering regions (1, 12), except in one case
(FL989) (13) . In the case of FL989, the 5' flanking region ofthebcl-2 genewas rear-
ranged butjuxtaposed to IgH locus (13) . These results suggest that rearrangement
of bcl-2 gene occurs preferentially at its 5' flanking region in CLL and results in
the bcl-2/IgLjuxtaposition . This situation seems to be characteristic ofCLL be-
cause none of 22 cases of multiple myeloma samples tested thus far have shown the
bcl-2 gene rearrangement (Adachi,M., andY . Tsujimoto, unpublishedobservation).
We are intrigued to find that two different B cell tumors, follicular lymphoma
andCLL, are characterizedby chromosome translocations involvingthesame bcl-2
gene but different Ig loci . Several explanations can be advanced . The bcl-2 gene
might be activated in different ways by IgH and IgL genes at the transcriptional
level or through mutations of the protein coding region . The second possibility is
based on the timing of bcl-2 gene activation . The bcl-2 gene could be activated atADACHI ET AL.
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a pre-B stage in follicular lymphoma when IgH gene is rearranged (14) and at a
more mature B cell stage in CLL when IgL gene is rearranged, which in turn produces
the expanded pool of the prefollicular lymphoma or pre-CLL cells. The expansion
of activated B cells by the bcl-2 gene could enhance the chance of acquiring addi-
tional genetic alterations of different genes that define the nature of B cell tumors.
Regardless of the mechanism of the bcl-2 gene activation, our finding demon-
strates that the choice of breakpoint regions of an oncogene and of Ig genes as an
activator can characterize different malignancies of the B cell lineage.
Summary
Most of human follicular lymphomas possess the t(14;18) chromosome transloca-
tion thatjuxtaposes the IgH gene to the 3' region of bcl-2 in a head-to-tail configura-
tion. Here we show that the rearrangement of the bcl-2 gene occurs in a significant
fraction (N10%) of B cell CLL. In all cases analyzed, breakpoints on chromosome
18 clustered at the 5' flanking region ofthe bcl-2 gene, and no rearrangements were
found at the major or minor breakpoint clustering region (3' region of bcl-2 gene)
typical of the t(14;18) chromosome translocation. All of the rearranged bcl-2 genes
werejuxtaposed with the IgX or « genes in a head-to-head configuration. These results
imply that the bcl-2 gene is preferentially linked to the IgL genes in CLL and could
function in leukemogenesis.
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